Jazz Pharmaceuticals (JAZZ) Construction in Progress (2010 - 2016)

Jazz Pharmaceuticals (JAZZ) recorded quarterly Construction in Progress of $66.2 million in Q1 2016, up 5.04% quarter-over-quarter from $63.0 million in Q4 2015, and up 33.85% on a YoY basis from $49.4 million in Q2 2015.

Jazz Pharmaceuticals (JAZZ) Construction in Progress (2010 - 2016) Analysis & Trends

Jazz Pharmaceuticals' Construction in Progress history runs 7 years deep, the most recent figure standing at $66.2 million for Q1 2016.

  • In Q1 2016, Construction in Progress rose 33.85% year-over-year to $66.2 million; the TTM figure through Mar 2016 stood at $66.2 million (up 33.85% YoY), while the FY2015 annual figure was $63.0 million, up 69.63% from the prior year.
  • Construction in Progress was $66.2 million for Q1 2016 at Jazz Pharmaceuticals, up from $63.0 million in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $66.2 million in Q1 2016 to a low of $148000.0 in Q1 2012.
  • Historically, Construction in Progress has averaged $24.0 million across 5 years, with a median of $10.6 million in 2014.
  • The sharpest annual moves came in 2013 and 2016: Construction in Progress jumped 1239.19% in 2013, then jumped 33.85% in 2016.
  • A 5-year view of Construction in Progress shows it stood at $1.1 million in 2012, then surged by 286.61% to $4.4 million in 2013, then surged by 746.51% to $37.1 million in 2014, then jumped by 69.63% to $63.0 million in 2015, then gained by 5.04% to $66.2 million in 2016.
  • The last three Construction in Progress figures came in at $66.2 million (Q1 2016), $63.0 million (Q4 2015), and $61.1 million (Q3 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Jazz Pharmaceuticals 13.91 Bn 12.06 Bn 934.80 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2016 66.19 Mn
Dec 31, 2015 63.01 Mn
Sep 30, 2015 61.06 Mn
Jun 30, 2015 57.88 Mn
Mar 31, 2015 49.45 Mn
Dec 31, 2014 37.15 Mn
Sep 30, 2014 24.25 Mn
Jun 30, 2014 18.04 Mn
Mar 31, 2014 10.64 Mn
Dec 31, 2013 4.39 Mn
Sep 30, 2013 5.06 Mn
Jun 30, 2013 4.20 Mn
Mar 31, 2013 1.98 Mn
Dec 31, 2012 1.14 Mn
Sep 30, 2012 1.05 Mn
Jun 30, 2012 2.46 Mn
Mar 31, 2012 148,000.00
Dec 31, 2011 689,000.00
Dec 31, 2010 73,000.00